| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterocolitis, Necrotizing | 22 | 2024 | 82 | 7.980 |
Why?
|
| Gastrointestinal Microbiome | 24 | 2025 | 590 | 7.050 |
Why?
|
| Infant, Premature | 20 | 2024 | 308 | 4.310 |
Why?
|
| Probiotics | 11 | 2023 | 92 | 4.230 |
Why?
|
| Microbiota | 12 | 2024 | 426 | 3.360 |
Why?
|
| Intestinal Mucosa | 21 | 2021 | 825 | 3.110 |
Why?
|
| Dysbiosis | 5 | 2024 | 91 | 2.510 |
Why?
|
| Infant, Newborn | 27 | 2024 | 2614 | 2.150 |
Why?
|
| Intestines | 12 | 2023 | 431 | 2.080 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2022 | 118 | 1.330 |
Why?
|
| Infant | 15 | 2024 | 3363 | 1.190 |
Why?
|
| Child Development | 2 | 2021 | 174 | 1.180 |
Why?
|
| Brain | 7 | 2025 | 2482 | 1.130 |
Why?
|
| Inflammation | 6 | 2015 | 1068 | 1.060 |
Why?
|
| Germ-Free Life | 6 | 2025 | 83 | 1.030 |
Why?
|
| Anti-Bacterial Agents | 5 | 2021 | 847 | 0.990 |
Why?
|
| Bacteria | 7 | 2025 | 517 | 0.960 |
Why?
|
| Milk, Human | 5 | 2023 | 51 | 0.950 |
Why?
|
| Pregnancy | 13 | 2025 | 3240 | 0.920 |
Why?
|
| Epithelial Cells | 8 | 2013 | 705 | 0.900 |
Why?
|
| Infant, Premature, Diseases | 2 | 2019 | 85 | 0.880 |
Why?
|
| Enteral Nutrition | 4 | 2021 | 105 | 0.880 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2024 | 176 | 0.870 |
Why?
|
| Feces | 8 | 2024 | 360 | 0.840 |
Why?
|
| Vitamin B 12 | 1 | 2024 | 25 | 0.830 |
Why?
|
| NF-kappa B | 7 | 2015 | 469 | 0.800 |
Why?
|
| Erythropoietin | 3 | 2013 | 91 | 0.770 |
Why?
|
| Animals, Newborn | 7 | 2021 | 535 | 0.730 |
Why?
|
| Infant Health | 1 | 2021 | 3 | 0.720 |
Why?
|
| Animals | 39 | 2025 | 28919 | 0.700 |
Why?
|
| Dexamethasone | 2 | 2021 | 351 | 0.700 |
Why?
|
| Humans | 58 | 2025 | 96112 | 0.690 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2021 | 7 | 0.680 |
Why?
|
| Clostridiales | 1 | 2021 | 18 | 0.670 |
Why?
|
| Bacteroidetes | 1 | 2021 | 40 | 0.660 |
Why?
|
| Protective Agents | 1 | 2020 | 34 | 0.640 |
Why?
|
| Rats | 11 | 2021 | 4155 | 0.640 |
Why?
|
| Mice | 25 | 2025 | 12541 | 0.620 |
Why?
|
| Retinopathy of Prematurity | 1 | 2020 | 75 | 0.590 |
Why?
|
| Infant Formula | 1 | 2018 | 18 | 0.590 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2014 | 112 | 0.540 |
Why?
|
| Cesarean Section | 1 | 2018 | 157 | 0.530 |
Why?
|
| Receptors, Calcitriol | 4 | 2023 | 131 | 0.500 |
Why?
|
| Prebiotics | 1 | 2016 | 8 | 0.490 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 241 | 0.490 |
Why?
|
| I-kappa B Proteins | 3 | 2007 | 54 | 0.490 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 2550 | 0.480 |
Why?
|
| Opportunistic Infections | 1 | 2015 | 60 | 0.470 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 103 | 0.460 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2016 | 80 | 0.460 |
Why?
|
| Platelet Activating Factor | 2 | 2008 | 53 | 0.460 |
Why?
|
| Dietary Supplements | 1 | 2016 | 133 | 0.460 |
Why?
|
| Female | 27 | 2025 | 50045 | 0.450 |
Why?
|
| Tight Junctions | 6 | 2015 | 153 | 0.450 |
Why?
|
| Autophagy | 2 | 2014 | 177 | 0.440 |
Why?
|
| Apoptosis | 3 | 2013 | 1760 | 0.440 |
Why?
|
| Metagenome | 3 | 2017 | 116 | 0.440 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2024 | 259 | 0.430 |
Why?
|
| Blood-Brain Barrier | 2 | 2025 | 80 | 0.410 |
Why?
|
| Smad Proteins | 1 | 2013 | 44 | 0.410 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2011 | 118 | 0.400 |
Why?
|
| Gastrointestinal Diseases | 2 | 2018 | 154 | 0.400 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 89 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2015 | 713 | 0.380 |
Why?
|
| Interleukin-8 | 4 | 2013 | 88 | 0.370 |
Why?
|
| Ileum | 2 | 2020 | 169 | 0.370 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 555 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 14 | 2025 | 3490 | 0.340 |
Why?
|
| Milk | 1 | 2011 | 56 | 0.340 |
Why?
|
| DNA Methylation | 1 | 2016 | 703 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 677 | 0.320 |
Why?
|
| Infant, Extremely Premature | 2 | 2022 | 43 | 0.310 |
Why?
|
| Delivery, Obstetric | 2 | 2021 | 124 | 0.300 |
Why?
|
| Zonula Occludens-1 Protein | 4 | 2015 | 70 | 0.300 |
Why?
|
| Chloride Channel Agonists | 1 | 2008 | 5 | 0.280 |
Why?
|
| Colitis | 3 | 2016 | 262 | 0.280 |
Why?
|
| Flagellin | 2 | 2008 | 18 | 0.280 |
Why?
|
| Acidosis | 1 | 2008 | 56 | 0.280 |
Why?
|
| Child | 4 | 2024 | 7625 | 0.270 |
Why?
|
| Enterocytes | 3 | 2016 | 27 | 0.250 |
Why?
|
| Biodiversity | 1 | 2009 | 238 | 0.250 |
Why?
|
| Colon | 5 | 2013 | 541 | 0.250 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2017 | 53 | 0.250 |
Why?
|
| NF-KappaB Inhibitor alpha | 3 | 2020 | 44 | 0.250 |
Why?
|
| Salmonella Infections | 3 | 2012 | 18 | 0.240 |
Why?
|
| Salmonella Infections, Animal | 3 | 2015 | 11 | 0.230 |
Why?
|
| Gastrointestinal Tract | 3 | 2018 | 197 | 0.230 |
Why?
|
| Cell Line | 7 | 2015 | 2537 | 0.230 |
Why?
|
| Salmonella | 3 | 2012 | 14 | 0.220 |
Why?
|
| RNA, Messenger | 7 | 2018 | 2090 | 0.220 |
Why?
|
| Immunity, Innate | 3 | 2013 | 464 | 0.210 |
Why?
|
| Head | 2 | 2024 | 131 | 0.210 |
Why?
|
| Health | 2 | 2021 | 29 | 0.210 |
Why?
|
| Gene Expression | 6 | 2013 | 1320 | 0.210 |
Why?
|
| Gestational Age | 3 | 2020 | 343 | 0.210 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 49 | 0.200 |
Why?
|
| Bacterial Proteins | 4 | 2012 | 922 | 0.200 |
Why?
|
| Vitamins | 1 | 2024 | 86 | 0.200 |
Why?
|
| Male | 11 | 2025 | 45871 | 0.200 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 253 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3652 | 0.190 |
Why?
|
| Chlorides | 1 | 2002 | 108 | 0.180 |
Why?
|
| Phylogeny | 5 | 2016 | 1275 | 0.180 |
Why?
|
| Body Weight | 2 | 2020 | 460 | 0.180 |
Why?
|
| Salmonella typhimurium | 3 | 2015 | 32 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2022 | 32 | 0.180 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 305 | 0.170 |
Why?
|
| Weaning | 2 | 2014 | 26 | 0.170 |
Why?
|
| Adolescent | 3 | 2024 | 9895 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 164 | 0.170 |
Why?
|
| Membrane Proteins | 3 | 2013 | 1276 | 0.170 |
Why?
|
| Caspase 3 | 2 | 2013 | 164 | 0.170 |
Why?
|
| Cognition | 1 | 2025 | 635 | 0.170 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2020 | 3 | 0.160 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2020 | 4 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 367 | 0.160 |
Why?
|
| Maternal Inheritance | 1 | 2020 | 4 | 0.160 |
Why?
|
| Lactobacillus acidophilus | 1 | 2020 | 7 | 0.160 |
Why?
|
| Mucus | 1 | 2020 | 19 | 0.160 |
Why?
|
| Sepsis | 2 | 2023 | 391 | 0.160 |
Why?
|
| Muramidase | 1 | 2020 | 37 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2020 | 1267 | 0.160 |
Why?
|
| Birth Weight | 2 | 2017 | 152 | 0.160 |
Why?
|
| Interferon-gamma | 2 | 2013 | 467 | 0.160 |
Why?
|
| Docosahexaenoic Acids | 1 | 2020 | 35 | 0.160 |
Why?
|
| Central Nervous System | 1 | 2020 | 154 | 0.160 |
Why?
|
| Phosphoproteins | 2 | 2011 | 263 | 0.160 |
Why?
|
| Immune System | 1 | 2020 | 103 | 0.160 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 2061 | 0.150 |
Why?
|
| Environment | 1 | 2020 | 231 | 0.150 |
Why?
|
| Bioreactors | 1 | 2018 | 11 | 0.140 |
Why?
|
| Ubiquitin | 3 | 2009 | 95 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2021 | 221 | 0.140 |
Why?
|
| Health Status | 1 | 2020 | 386 | 0.140 |
Why?
|
| RNA Interference | 2 | 2011 | 385 | 0.140 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 21 | 0.140 |
Why?
|
| Heat-Shock Proteins | 2 | 2010 | 184 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2013 | 281 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2020 | 252 | 0.140 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2017 | 12 | 0.130 |
Why?
|
| Oligodendroglia | 1 | 2018 | 122 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 116 | 0.130 |
Why?
|
| Pharmaceutical Preparations | 1 | 2018 | 97 | 0.130 |
Why?
|
| Placenta | 1 | 2018 | 191 | 0.130 |
Why?
|
| Administration, Oral | 2 | 2020 | 688 | 0.130 |
Why?
|
| Clostridium Infections | 2 | 2016 | 128 | 0.130 |
Why?
|
| Permeability | 2 | 2020 | 144 | 0.120 |
Why?
|
| Enterotoxins | 1 | 2016 | 22 | 0.120 |
Why?
|
| Biological Therapy | 1 | 2016 | 47 | 0.120 |
Why?
|
| HT29 Cells | 3 | 2012 | 50 | 0.120 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2016 | 52 | 0.120 |
Why?
|
| Colostrum | 1 | 2015 | 2 | 0.120 |
Why?
|
| beta Catenin | 3 | 2012 | 266 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 2016 | 115 | 0.120 |
Why?
|
| Premature Birth | 1 | 2017 | 130 | 0.120 |
Why?
|
| Claudins | 1 | 2015 | 34 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2018 | 394 | 0.110 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 126 | 0.110 |
Why?
|
| Aging | 1 | 2020 | 766 | 0.110 |
Why?
|
| Chymotrypsin | 1 | 2014 | 28 | 0.110 |
Why?
|
| Trypsin | 1 | 2014 | 95 | 0.110 |
Why?
|
| Lactobacillus plantarum | 2 | 2015 | 4 | 0.110 |
Why?
|
| Hydrolysis | 1 | 2014 | 146 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 1179 | 0.110 |
Why?
|
| Protein Subunits | 1 | 2014 | 126 | 0.110 |
Why?
|
| Neoplasm Proteins | 2 | 2008 | 553 | 0.100 |
Why?
|
| Fetus | 2 | 2007 | 239 | 0.100 |
Why?
|
| Lung | 1 | 2020 | 1382 | 0.100 |
Why?
|
| Diffusion | 1 | 2013 | 95 | 0.100 |
Why?
|
| Smad2 Protein | 1 | 2013 | 24 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 156 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2013 | 3581 | 0.100 |
Why?
|
| Caco-2 Cells | 3 | 2016 | 125 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2014 | 286 | 0.100 |
Why?
|
| Beclin-1 | 1 | 2013 | 15 | 0.100 |
Why?
|
| Asthma | 1 | 2022 | 1051 | 0.100 |
Why?
|
| Spin Labels | 1 | 2013 | 107 | 0.100 |
Why?
|
| Child, Preschool | 1 | 2020 | 3974 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 180 | 0.100 |
Why?
|
| Alprostadil | 1 | 2013 | 26 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 326 | 0.100 |
Why?
|
| Biota | 1 | 2013 | 21 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 124 | 0.100 |
Why?
|
| Neurons | 2 | 2018 | 1653 | 0.090 |
Why?
|
| Axin Protein | 1 | 2012 | 4 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 204 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 187 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 217 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 2778 | 0.090 |
Why?
|
| Phenotype | 1 | 2018 | 2579 | 0.090 |
Why?
|
| Cytoprotection | 1 | 2011 | 51 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2011 | 112 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2011 | 280 | 0.080 |
Why?
|
| Biological Products | 1 | 2013 | 179 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 910 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 996 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 284 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1958 | 0.080 |
Why?
|
| Cytoplasmic Granules | 1 | 2010 | 99 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 185 | 0.080 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 54 | 0.080 |
Why?
|
| Heat-Shock Response | 1 | 2010 | 54 | 0.080 |
Why?
|
| Escherichia coli | 2 | 2020 | 627 | 0.080 |
Why?
|
| DNA, Ribosomal | 1 | 2009 | 55 | 0.080 |
Why?
|
| Time Factors | 2 | 2015 | 5585 | 0.070 |
Why?
|
| Cecum | 3 | 2015 | 78 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 740 | 0.070 |
Why?
|
| Sodium-Hydrogen Exchanger 1 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Fura-2 | 1 | 2008 | 22 | 0.070 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2008 | 18 | 0.070 |
Why?
|
| Egtazic Acid | 1 | 2008 | 33 | 0.070 |
Why?
|
| Mucins | 2 | 2020 | 40 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 801 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2008 | 65 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2010 | 1157 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2008 | 43 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2011 | 483 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2009 | 393 | 0.070 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2008 | 78 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2008 | 68 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 399 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2008 | 406 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 42 | 0.060 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 49 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 509 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 90 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 465 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 935 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 2474 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 262 | 0.060 |
Why?
|
| Hypoxia | 1 | 2011 | 682 | 0.060 |
Why?
|
| Protein Transport | 1 | 2007 | 439 | 0.060 |
Why?
|
| Paneth Cells | 2 | 2015 | 10 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3040 | 0.050 |
Why?
|
| Clostridium | 1 | 2024 | 24 | 0.050 |
Why?
|
| Peptides | 1 | 2008 | 672 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2011 | 797 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 611 | 0.050 |
Why?
|
| HCT116 Cells | 2 | 2015 | 164 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 683 | 0.050 |
Why?
|
| Calcium | 1 | 2008 | 1205 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2003 | 71 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 116 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 18 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2002 | 44 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2003 | 166 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2002 | 119 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2002 | 284 | 0.040 |
Why?
|
| Mothers | 1 | 2023 | 155 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 412 | 0.040 |
Why?
|
| Digestive System | 1 | 2001 | 42 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 1010 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2001 | 38 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 28725 | 0.040 |
Why?
|
| Publications | 1 | 2021 | 32 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 298 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2002 | 442 | 0.040 |
Why?
|
| Food | 1 | 2001 | 93 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2010 | 2940 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 349 | 0.040 |
Why?
|
| Disease | 1 | 2021 | 93 | 0.040 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2020 | 5 | 0.040 |
Why?
|
| Epigenomics | 1 | 2021 | 109 | 0.040 |
Why?
|
| Enterobacter cloacae | 1 | 2020 | 8 | 0.040 |
Why?
|
| Fucose | 1 | 2020 | 14 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 398 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2161 | 0.040 |
Why?
|
| Mental Health | 1 | 2021 | 202 | 0.040 |
Why?
|
| Models, Biological | 2 | 2010 | 1810 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 380 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 901 | 0.040 |
Why?
|
| Protein Binding | 2 | 2015 | 1560 | 0.040 |
Why?
|
| Maze Learning | 1 | 2018 | 32 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 84 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1973 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2018 | 28 | 0.040 |
Why?
|
| Age Factors | 1 | 2003 | 1963 | 0.040 |
Why?
|
| Risk Factors | 2 | 2022 | 5961 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2022 | 815 | 0.030 |
Why?
|
| Gray Matter | 1 | 2018 | 43 | 0.030 |
Why?
|
| Cell Count | 1 | 2018 | 203 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 481 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2018 | 85 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 376 | 0.030 |
Why?
|
| Ribotyping | 1 | 2017 | 12 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 379 | 0.030 |
Why?
|
| White Matter | 1 | 2018 | 96 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 1715 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1829 | 0.030 |
Why?
|
| Metagenomics | 1 | 2017 | 100 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2017 | 159 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 284 | 0.030 |
Why?
|
| Perinatal Mortality | 1 | 2015 | 1 | 0.030 |
Why?
|
| Claudin-1 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2015 | 19 | 0.030 |
Why?
|
| Tight Junction Proteins | 1 | 2015 | 14 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2015 | 67 | 0.030 |
Why?
|
| Social Behavior | 1 | 2018 | 309 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2015 | 82 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 297 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 162 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2016 | 200 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 439 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 139 | 0.030 |
Why?
|
| DNA | 1 | 2020 | 1333 | 0.030 |
Why?
|
| Neutrophils | 1 | 2015 | 332 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 297 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 586 | 0.030 |
Why?
|
| United States | 2 | 2017 | 7768 | 0.020 |
Why?
|
| Lubiprostone | 1 | 2013 | 3 | 0.020 |
Why?
|
| Mice, Inbred CFTR | 1 | 2013 | 4 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 777 | 0.020 |
Why?
|
| Anions | 1 | 2013 | 31 | 0.020 |
Why?
|
| Ion Transport | 1 | 2013 | 87 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 526 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2015 | 483 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2013 | 57 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 1167 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2013 | 112 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 81 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 631 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 872 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1791 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 103 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 270 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 36 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 93 | 0.020 |
Why?
|
| Jejunum | 1 | 2010 | 80 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 256 | 0.020 |
Why?
|
| T-Cell Intracellular Antigen-1 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2010 | 18 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2010 | 18 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2010 | 37 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 19 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 156 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 50 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 149 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 100 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 75 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 43 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 47 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 58 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 728 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 522 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2008 | 35 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 516 | 0.020 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Cyclin D | 1 | 2007 | 15 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 130 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 81 | 0.020 |
Why?
|
| Oxidants | 1 | 2008 | 86 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 126 | 0.020 |
Why?
|
| Cyclins | 1 | 2007 | 80 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 127 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 305 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 224 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 1220 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 152 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1755 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 563 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 897 | 0.010 |
Why?
|
| Macrophages | 1 | 2009 | 626 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 1030 | 0.010 |
Why?
|
| Homeostasis | 1 | 2008 | 467 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2009 | 541 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 7230 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 9176 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 20972 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28371 | 0.010 |
Why?
|